BradleyAJLenox-SmithAJ (2013) Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. J Psychopharmacol27: 740–758.
DelgadoPLMillerHLSalomonRM. (1999) Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol Psychiatry46: 212–220.
4.
MillerHLDelgadoPLSalomonRM. (1996) Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry53: 117–128.
PringleAMcCabeCCowenPJHarmerCJ (2013) Antidepressant treatment and emotional processing: can we dissociate the roles of serotonin and noradrenaline?J Psychopharmacol27: 719–731.
7.
SzabadiE (2013) Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol27: 659–693.
8.
UherRMaierWHauserJ. (2009) Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry194: 252–259.
9.
WhiskeyETaylorD (2013) A review of the adverse effects and safety of noradrenergic antidepressantsPsychopharmacol27: 732–739.
10.
WilesNJMulliganJPetersTJ. (2012) Severity of depression and response to antidepressants: GENPOD randomised controlled trial. Br J Psychiatry200: 130–136.
